Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-06-11, Stock:PFE, The news for the past five days is as follows:
2020-06-04: NEWS1: Gates Pledges $1.6 Billion for Vaccines. What That Means for Covid-19 and Other Diseases..NEWS2: Trump Picks 5 Coronavirus Vaccine Candidates Per NYT Report.NEWS3: Gates Pledges $1.6 Billion for Vaccines. What That Means for Covid-19 and Other Diseases..NEWS4: 5 Promising Covid-19 Vaccines Now Selected For Trump’s Operation Warp Speed.
2020-06-05: NEWS1: Don’t Judge Pfizer by Its Vaccine Efforts.NEWS2: Coronavirus update: Payrolls spark hope for a fast rebound as Novavax gets a boost in vaccine race.NEWS3: Pharma Stock Roundup: LLY Coronavirus Antibody Phase I Study Initiation, FDA Approvals.
2020-06-08: NEWS1: Vertex CEO Provided Best Value for Investors.NEWS2: Tailoring Portfolios to Coronavirus and Recession.NEWS3: 2 Top Pharma Stocks to Buy in June.NEWS4: Pfizer Is Charging Ahead With A Coronavirus Vaccine — Is PFE Stock A Buy?.NEWS5: Drugmakers Target Coronavirus Vaccine in 2020: 4 Stocks in Focus.
2020-06-09: NEWS1: Pfizer (PFE) Dips More Than Broader Markets: What You Should Know.NEWS2: Roche, Johnson & Johnson Top R&D Spenders in 2019.
2020-06-10: NEWS1: Fauci: Sped-up production on coronavirus vaccine risky and costly — but worth it.NEWS2: Buy Pfizer (PFE) Stock for Massive Upside Ahead.NEWS3: Pfizer’s Abrocitinib Candidate Shows Positive Results In Kids With Atopic Dermatitis.NEWS4: Pfizer Announces Positive Top-Line Results from JADE TEEN Trial of Abrocitinib in Adolescents with Moderate-to-Severe Atopic Dermatitis.

Answer: Decrease